CELG : Summary for Celgene Corporation - Yahoo Finance

Canadian Markets closed

Celgene Corporation (CELG)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
115.22+0.27 (+0.23%)
At close: 4:00PM EST

115.15 -0.07 (-0.06%)
After hours: 4:54PM EST

People also watch
GILDBIIBREGNAMGNALXN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close114.95
Open115.10
Bid114.60 x 100
Ask115.22 x 200
Day's Range114.29 - 115.25
52 Week Range93.05 - 127.00
Volume3,461,183
Avg. Volume4,948,632
Market Cap89.32B
Beta1.59
PE Ratio (TTM)43.76
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen
    Investor's Business Daily42 minutes ago

    Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen

    Gilead will likely guide to declining 2017 sales, hamstrung on limited Hep C visibility, RBC said Wednesday.

  • Celgene Corp. – Value Analysis (NASDAQ:CELG) : January 18, 2017
    Capital Cube4 hours ago

    Celgene Corp. – Value Analysis (NASDAQ:CELG) : January 18, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Celgene Corp. a score of 69. Our analysis is based on comparing Celgene Corp. with the following peers – Amgen Inc., Gilead Sciences, Inc., Biogen Inc., OncoMed Pharmaceuticals, Inc., Eli Lilly and Company, Johnson & Johnson, Alexion Pharmaceuticals, Inc., Illumina, Inc., Epizyme, Inc. and ARIAD Pharmaceuticals, Inc. ... Read more (Read more...)

  • Benzinga7 hours ago

    Orphan Drugs Among 2015's Top 10 Best-Selling Medications

    Orphan drugs , drugs intended to prevent, diagnose or treat rare diseases/disorders, are huge sellers for the pharmaceutical industry. NPR, citing data from EvaluatePharma, noted that seven of the 10 best-selling ...